"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with Chronic obstructive pulmonary disease

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Ilie, Marius ^a,b   Hofman, Véronique ^a,b   Long Mira, Elodie ^a,b   Selva, Eric ^a   Vignaud, Jean Michel ^c   Padovani, Bernard ^a   Mouroux, Jérôme ^a   Marquette, Charles Hugo ^a,b   Hofman, Paul ^a,b  

^a PASTEUR HOSPITAL   (France)

^b UNIVERSITY OF NICE SOPHIA ANTIPOLIS   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN; PROTEIN KINASE LKB1; TUMOR MARKER;

ADULT; AGED; ALK GENE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CELL ISOLATION; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIRCULATING TUMOR CELL; CONTROLLED STUDY; CYTOPATHOLOGY; EARLY DIAGNOSIS; EGFR GENE; EML4 GENE; FEMALE; GENE; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; ONCOGENE K RAS; PREDICTIVE VALUE; RISK ASSESSMENT; SENTINEL CIRCULATING TUMOR CELL; SMOKING; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STK11 GENE; COMPLICATION; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MIDDLE AGED; PATHOLOGY; PROCEDURES; TUMOR EMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84910008796     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111597     Document Type: Article

References (48)

1. Blanchon F, Grivaux M, Asselain B, Lebas FX, Orlando JP, et al. (2006) 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index. Lancet Oncol 7: 829-836.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
3. Farlow EC, Patel K, Basu S, Lee BS, Kim AW, et al. (2010) Development of a multiplexed tumor-associated autoantibody-based blood test for the detection of non-small cell lung cancer. Clin Cancer Res 16: 3452-3462.
4. Farlow EC, Vercillo MS, Coon JS, Basu S, Kim AW, et al. (2010) A multi-analyte serum test for the detection of non-small cell lung cancer. Br J Cancer 103: 1221-1228.
5. Patz EF Jr, Campa MJ, Gottlin EB, Kusmartseva I, Guan XR, et al. (2007) Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol 25: 5578-5583.
6. Aberle DR, Berg CD, Black WC, Church TR, Fagerstrom RM, et al. (2011) The National Lung Screening Trial: overview and study design. Radiology 258: 243-253.
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
8. Lee G, Walser TC, Dubinett SM (2009) Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 15: 303-307.
9. McGarvey LP, John M, Anderson JA, Zvarich M, Wise RA (2007) Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 62: 411-415.
10. Mannino DM, Aguayo SM, Petty TL, Redd SC (2003) Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 163: 1475-1480.
11. Parimon T, Chien JW, Bryson CL, McDonell MB, Udris EM, et al. (2007) Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 175: 712-719.
12. Schwartz AG, Cote ML, Wenzlaff AS, Van Dyke A, Chen W, et al. (2009) Chronic obstructive lung diseases and risk of non-small cell lung cancer in women. J Thorac Oncol 4: 291-299.
13. Sekine Y, Yamada Y, Chiyo M, Iwata T, Nakajima T, et al. (2007) Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection. Ann Thorac Surg 84: 946-950.
14. Adcock IM, Caramori G, Barnes PJ (2011) Chronic obstructive pulmonary disease and lung cancer: new molecular insights. Respiration 81: 265-284.
15. Boelens MC, Gustafson AM, Postma DS, Kok K, van der Vries G, et al. (2011) A chronic obstructive pulmonary disease related signature in squamous cell lung cancer. Lung Cancer 72: 177-183.
16. de Torres JP, Marin JM, Casanova C, Cote C, Carrizo S, et al. (2011) Lung cancer in patients with chronic obstructive pulmonary disease- incidence and predicting factors. Am J Respir Crit Care Med 184: 913-919.
17. Houghton AM (2013) Mechanistic links between COPD and lung cancer. Nat Rev Cancer 13: 233-245.
18. Pantel K, Brakenhoff RH, Brandt B (2008) Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340.
19. Paterlini-Brechot P, Benali NL (2007) Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett 253: 180-204.
20. Chang YS, di Tomaso E, McDonald DM, Jones R, Jain RK, et al. (2000) Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 97: 14608-14613.
21. Wittekind C, Neid M (2005) Cancer invasion and metastasis. Oncology 69 Suppl 1: 14-16.
22. Rhim AD, Mirek ET, Aiello NM, Maitra A, Bailey JM, et al. (2012) EMT and dissemination precede pancreatic tumor formation. Cell 148: 349-361.
23. Hofman V, Ilie MI, Long E, Selva E, Bonnetaud C, et al. (2011) Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch Assay and the isolation by size of epithelial tumor cell method. Int J Cancer 129: 1651-1660.
24. Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, et al. (2011) Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 17: 827-835.
25. Hofman V, Long E, Ilie M, Bonnetaud C, Vignaud JM, et al. (2012) Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology 23: 30-38.
26. Hofman VJ, Ilie MI, Bonnetaud C, Selva E, Long E, et al. (2011) Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls. Am J Clin Pathol 135: 146-156.
27. Mazzone P, Mekhail T (2012) Current and emerging medical treatments for non-small cell lung cancer: a primer for pulmonologists. Respir Med 106: 473-492.
28. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
29. Rodriguez-Roisin R, Soriano JB (2008) Chronic obstructive pulmonary disease with lung cancer and/or cardiovascular disease. Proc Am Thorac Soc 5: 842-847.
30. Wasswa-Kintu S, Gan WQ, Man SF, Pare PD, Sin DD (2005) Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 60: 570-575.
31. Mets OM, Buckens CF, Zanen P, Isgum I, van Ginneken B, et al. (2011) Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 306: 1775-1781.
32. Parkinson DR, Dracopoli N, Petty BG, Compton C, Cristofanilli M, et al. (2012) Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 10: 138.
33. Kang Y, Pantel K (2013) Tumor cell dissemination: emerging biological insights from animal models and cancer patients. Cancer Cell 23: 573-581.
34. Uhr JW, Pantel K (2011) Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A 108: 12396-12400.
35. Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, et al. (2011) Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 105: 1338-1341.
36. Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, et al. (2012) Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 7: 306-315.
37. Hofman V, Bonnetaud C, Ilie MI, Vielh P, Vignaud JM, et al. (2011) Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker. Clin Cancer Res 17: 827-835.
38. Gray JW (2003) Evidence emerges for early metastasis and parallel evolution of primary and metastatic tumors. Cancer Cell 4: 4-6.
39. Kohn EC, Liotta LA (1995) Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res 55: 1856-1862.
40. Michaelson JS, Cheongsiatmoy JA, Dewey F, Silverstein MJ, Sgroi D, et al. (2005) Spread of human cancer cells occurs with probabilities indicative of a nongenetic mechanism. Br J Cancer 93: 1244-1249.
41. Deisboeck TS, Guiot C, Delsanto PP, Pugno N (2006) Does cancer growth depend on surface extension? Med Hypotheses 67: 1338-1341.
42. Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418: 823.
43. Collado M, Serrano M (2010) Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 10: 51-57.
44. Sarkisian CJ, Keister BA, Stairs DB, Boxer RB, Moody SE, et al. (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat Cell Biol 9: 493-505.
45. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, et al. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730.
46. Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, et al. (2011) Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Res 13: R67.
47. Yu JQ, Cristofanilli M (2011) Circulating tumor cells and PET. J Nucl Med 52: 1501-1504.
48. Witney TH, Carroll L, Alam IS, Chandrashekran A, Nguyen QD, et al. (2014) A novel radiotracer to image glycogen metabolism in tumors by positron emission tomography. Cancer Res 74: 1319-1328.